Novartis moves ahead with copy of Roche drug
by on Jan.10, 2011, under Health and Fitness
Novartis advanced its bid to copy Roche's multi-billion dollar antibody drug rituximab on Monday, starting phase II trials for its own version of the blockbuster medicine.
View full post on Yahoo! Health News
